Eikon Therapeutics, Inc. (EIKN)
NASDAQ: EIKN · Real-Time Price · USD
14.91
+0.53 (3.69%)
At close: Mar 9, 2026, 4:00 PM EDT
14.92
+0.01 (0.07%)
After-hours: Mar 9, 2026, 4:45 PM EDT
Eikon Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Market Capitalization | 805 | - | - |
| Enterprise Value | 670 | - | - |
| Debt / Equity Ratio | 0.67 | 0.86 | 0.07 |
| Net Debt / Equity Ratio | -0.38 | -0.07 | -0.85 |
| Net Debt / EBITDA Ratio | 0.48 | 0.07 | 1.57 |
| Net Debt / FCF Ratio | 0.53 | 0.08 | 1.82 |
| Quick Ratio | 8.47 | 3.90 | 13.69 |
| Current Ratio | 8.80 | 4.04 | 13.88 |
| Return on Equity (ROE) | - | -69.35% | - |
| Return on Assets (ROA) | - | -32.00% | - |
| Return on Capital Employed (ROCE) | -50.00% | -59.90% | -53.80% |
| Buyback Yield / Dilution | - | -24.34% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.